Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemiaMaribel Forero‐Castro, Jesús María Hernández‐Rivas, Jordi Ribera et al.|British Journal of Cancer|2017Cited by 51
Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromesMaría‐Teresa Cedena, Joaquín Martínez‐López, Inmaculada Rapado et al.|Oncotarget|2017Cited by 43
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY AllianceMarta Sobas, Lars Bullinger, Amin T. Turki et al.|Haematologica|2024Cited by 7
Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic SyndromesMaría‐Teresa Cedena, Joaquín Martínez‐López, Inmaculada Rapado et al.|Leukemia Research|2017Cited by 6
Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell TransplantationMarta Sobas, Jesús María Hernández‐Rivas, Javier Martínez Elicegui et al.|Blood|2021Cited by 4